US › Healthcare

Creative Medical Technology Holdings Inc (CELZ)

US · Healthcare · Biotechnology

$0.88+6.75%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.5M

EPS

$-0.41

EPS estimate

$-0.39

EPS came in at -0.41 against a street estimate of -0.39 — a miss of 5.1%.

Key statistics

Market cap

$6.3M

Forward P/E

0.0

P/B

0.73

Book value

$1.33

EPS (TTM)

$-2.05

52-week high

$6.25

52-week low

$0.62

50-day MA

$1.01

200-day MA

$1.81

Beta

2.04

Analyst view

Analysts rate Creative Medical Technology Holdings Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $20.00.

Shareholding

Insiders

0.53%

Institutions

5.66%

Largest institutional holders

Fund	Stake
Hudson Bay Capital Management LP	2.05%
Anson Funds Management LP	1.60%
Geode Capital Management, LLC	0.58%
Vanguard Capital Management, LLC	0.31%
XTX Topco Ltd	0.22%
Susquehanna International Group, LLP	0.16%
Vanguard Fiduciary Trust Co	0.08%
Wells Fargo & Co	0.08%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Creative Medical Technology Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.